BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18038913)

  • 1. Formulation and evaluation of less-painful clarithromycin lipid microspheres.
    LingHao Q; Wei L
    Arch Pharm Res; 2007 Oct; 30(10):1336-43. PubMed ID: 18038913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clarithromycin-loaded liposomes offering high drug loading and less irritation.
    Liu X; Sun W; Zhang B; Tian B; Tang X; Qi N; He H; Li H; Jin X
    Int J Pharm; 2013 Feb; 443(1-2):318-27. PubMed ID: 23337631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and evaluation of nimodipine-loaded lipid microspheres.
    Yu J; He HB; Tang X
    J Pharm Pharmacol; 2006 Nov; 58(11):1429-35. PubMed ID: 17132204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preparation and evaluation of clarithromycin emulsion for injection].
    Qin LH; Tang X
    Yao Xue Xue Bao; 2006 Oct; 41(10):945-9. PubMed ID: 17184111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation, preparation and evaluation of flunarizine-loaded lipid microspheres.
    Wang YJ; Wang J; Zhang HY; He HB; Tang X
    J Pharm Pharmacol; 2007 Mar; 59(3):351-7. PubMed ID: 17331337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and thermal sterile stability of a less painful intravenous clarithromycin emulsion containing vitamin E.
    Lu Y; Wang Y; Tang X
    Int J Pharm; 2008 Jan; 346(1-2):47-56. PubMed ID: 17640833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A lipid microsphere vehicle for vinorelbine: Stability, safety and pharmacokinetics.
    Zhang HY; Tang X; Li HY; Liu XL
    Int J Pharm; 2008 Feb; 348(1-2):70-9. PubMed ID: 17719191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of tocol emulsions for the intravenous delivery of clarithromycin.
    Li J; Nie S; Yang X; Wang C; Cui S; Pan W
    Int J Pharm; 2008 May; 356(1-2):282-90. PubMed ID: 18289806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A less irritant norcantharidin lipid microspheres: formulation and drug distribution.
    Lixin W; Haibing H; Xing T; Ruiying S; Dawei C
    Int J Pharm; 2006 Oct; 323(1-2):161-7. PubMed ID: 16828998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and evaluation of an injectable clarithromycin lipid-based complex in vitro and in vivo.
    Ma Y; Li H; Guan S
    Drug Deliv; 2013 Nov; 20(8):349-55. PubMed ID: 24032596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation of an intravenous emulsion loaded with a clarithromycin-phospholipid complex and its pharmacokinetics in rats.
    Lu Y; Zhang Y; Yang Z; Tang X
    Int J Pharm; 2009 Jan; 366(1-2):160-9. PubMed ID: 18835427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capacity of cholesteryl hemisuccinate in ion pair/phospholipid complex to improve drug-loading, stability and antibacterial activity of clarithromycin intravenous lipid microsphere.
    Luo L; Chen Q; Gong H; Liu L; Zhou L; He H; Zhang Y; Yin T; Tang X
    Colloids Surf B Biointerfaces; 2018 Dec; 172():262-271. PubMed ID: 30173093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain targeting of resveratrol by nasal administration of chitosan-coated lipid microparticles.
    Trotta V; Pavan B; Ferraro L; Beggiato S; Traini D; Des Reis LG; Scalia S; Dalpiaz A
    Eur J Pharm Biopharm; 2018 Jun; 127():250-259. PubMed ID: 29486302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and evaluation of clarithromycin microspheres for eradication of Helicobacter pylori.
    Rajinikanth PS; Karunagaran LN; Balasubramaniam J; Mishra B
    Chem Pharm Bull (Tokyo); 2008 Dec; 56(12):1658-64. PubMed ID: 19043235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preparation and in vitro and in vivo evaluation of etoposide submicro-emulsion for intravenous injection].
    Tian LL; Tang X; He HB; Wang J
    Yao Xue Xue Bao; 2007 Aug; 42(8):892-7. PubMed ID: 17944242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and optimization of chemically stable lipid microspheres containing flunarizine.
    Chi N; Tang X; Xu H
    Drug Dev Ind Pharm; 2009 Jun; 35(6):738-45. PubMed ID: 19514990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucoadhesive gastroretentive microparticulate system for programmed delivery of famotidine and clarithromycin.
    Srivastava A; Verma A; Saraf S; Jain A; Tiwari A; Panda PK; Jain SK
    J Microencapsul; 2021 May; 38(3):151-163. PubMed ID: 33205689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and evaluation of lidocaine base ethosomes for transdermal delivery.
    Zhu X; Li F; Peng X; Zeng K
    Anesth Analg; 2013 Aug; 117(2):352-7. PubMed ID: 23744957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and Evaluation of Novel Solid Lipid Microparticles for the Sustained Release of Ofloxacin.
    Hooda A; Sradhanjali M; Popsy
    Pharm Nanotechnol; 2017; 5(4):329-341. PubMed ID: 29278216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of twelve clarithromycin dry syrup formulations-bitterness, grittiness and uniformity of drug loading.
    Ishizaka T; Okada S; Tokuyama E; Mukai J; Uchida T
    Chem Pharm Bull (Tokyo); 2008 Oct; 56(10):1389-94. PubMed ID: 18827376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.